| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |